27. Impairments of capitalised financial instruments

Impairments of capitalised financial instruments that are measured at amortised cost are as follows:

€ million

 

Category “loans and receivables”

 

thereof loans and advance credit granted

 

thereof other current receivables

As of 1/10/2015

 

100

 

(2)

 

(98)

Currency translation

 

−1

 

(0)

 

(−1)

Additions

 

50

 

(3)

 

(47)

Reversal

 

−23

 

(0)

 

(−23)

Utilisation

 

−18

 

(−2)

 

(−16)

Transfers

 

0

 

(0)

 

(0)

As of 30/9 – 1/10/2016

 

109

 

(4)

 

(105)

Currency translation

 

−2

 

(0)

 

(−2)

Additions

 

45

 

(1)

 

(44)

Reversal

 

−17

 

(0)

 

(−17)

Utilisation

 

−17

 

(0)

 

(−17)

Transfers

 

−1

 

(0)

 

(−1)

As of 30/9/2017

 

117

 

(4)

 

(113)

In the category “loans and receivables”, which particularly includes loans, trade receivables, receivables from suppliers as well as receivables and other assets in the real estate area, negative earnings effects from impairment losses amount to €27 million (2015/16: €26 million). This also includes earnings from the receipt of cash from receivables that had already been derecognised in anticipation of irrevocability at €1 million (2015/16: €1 million). The current financial year includes reclassifications of impairment losses on assets held for sale in the amount of €1 million (2015/16: €0 million).

As in the , no earnings effects existed in the category “held to maturity” and from receivables from finance leases (carrying value according to IAS 17).

In principle, impairment losses on capitalised financial instruments are recognised using an adjustment account. They reduce the carrying amount of financial assets.

Previous year
Period of 12 months, usually cited as reference for statements in the annual report.
Glossary